In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug Trastuzumab (Herceptin (Regd) ) is associated with prolonged survival but also increases the risk of developing heart problems, a new systematic review shows. However, the review, published in The Cochrane Library, concludes that more women benefit from use of Trastuzumab than are harmed. The review focuses on treatment for women with advanced stage breast cancer who ...
You have just read an article categorized health
titled Benefits of Breast Cancer Drug Trastuzumab Outweigh the Risk of Harm.
Written by:
editor - Monday, February 2, 2015
There are currently no comments for "Benefits of Breast Cancer Drug Trastuzumab Outweigh the Risk of Harm"
Post a Comment